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Abstract.  Chinese hamster ovary cell populations 
were enriched for cells displaying low surface expres- 
sion of the  140-kD integrin fibronectin receptor (FnR) 
by means of fluorescence-activated cell sorting using 
monoclonal anti-FnR antibodies.  Selected cells were 
cloned by limiting dilution,  and the resulting clones 
were screened for low cell surface FnR expression by 
ELISA.  Two multiply sorted populations gave rise to 
variant clones possessing ,x,20 or 2%  FnR expression, 
respectively, compared with wild-type cells. Growth 
rates of the "20%" and "2%" clones on serum-coated 
plastic dishes were similar to that of wild-type cells. 
Variant cells expressing 20%  FnR could attach and 
spread on substrata coated with purified fibronectin, 
although  somewhat more slowly than wild-type cells, 
while cells expressing 2%  FnR could not attach or 
spread.  Cells from all variant clones attached normally 
to vitronectin substrata,  but some of the 2%  clones 
displayed altered morphology on this type of substra- 
tum.  Motility assays in blind well chambers showed a 
correlation of movement with level of expression of 
FnR.  The number of cells migrating  in response to 
fibronectin was greatly reduced compared with wild- 
type cells for the 20%  FnR variant clones, while vari- 
ant clones with 2%  FnR showed virtually no migra- 
tory activity. 
Surface labeling with  125I and immunoaflinity 
purification of FnR showed reduced levels of intact 
FnR on the plasma membranes of variants with 20% 
FnR, while none was detected in variants expressing 
2 % FnR.  Nevertheless, /3 subunits were detected on 
the surfaces of all variant clones. Immunoblots of cell 
lysates from wild-type cells and from both types of 
variant clones showed substantial amounts of FnR/3 
chain as well as enhanced amounts of a pre-/3 moiety 
in the variants,  ct chain was markedly reduced in the 
20% variants and essentially absent in the 2%  vari- 
ants,  indicating that failure to assemble intact FnR in 
these variants was due to deficiencies of ct chain 
production.  Dot blots of total mRNA from a represen- 
tative clone expressing 20%  FnR showed reduced lev- 
els of material hybridizing to an 0.97-kb hamster FnR 
ct chain eDNA probe as compared with wild type, 
while mRNA from a  representative clone expressing 
2%  FnR had no detectable hybridizable RNA; this 
seems to agree well with the results obtained by im- 
munoblotting.  Thus,  the defect in the variant clones 
seems to be due to reduced levels of c~ chain mRNA 
leading to a deficit of mature FnR and consequent al- 
terations in cell adhesion and motility on fibronectin 
substrata. 
T 
HE cell surface receptor for fibronectin  (FnR) ~ plays 
a  major role in  mediating  adhesive interactions  be- 
tween cells and the extracellular  matrix  (11, 31, 45). 
This intrinsic membrane glycoprotein of ~140 kD is a mem- 
ber of the integrin  superfamily of cell adhesion  receptors. 
Integrins  share a number of common features;  for example, 
they  are  composed of noncovalenfly  linked  beterodimers 
with large extracellular  domains.  In mammalian  cells, the 
integrin receptor superfamily is divided into three subfami- 
lies on the basis of three different  smaller (/3) subunits  that 
are shared by a number of larger unique (o0 subunits.  (Addi- 
tional/3 subunits have recently been described [13, 32.]) The 
1. Abbreviations used in this paper: CHO, Chinese hamster ovary; FACS, 
fluorescence-activated cell sorting; Fn, fibronectin; FnR, fibronectin recep- 
tor; Ln,  laminin; Vn, vitronectin; VnR, vitronectin receptor. 
/3j subfamily  includes  the FnR (in human cells designated 
as 0~5/3~) as well as at least five other known ¢xx/3z proteins, 
including receptors for collagen and laminin (Ln) (28, 36, 50, 
54-56). The second subfamily defined by the/32 subunit is 
mainly involved in leukocyte cell-cell interaction and, as such, 
participates  in  immune  and  inflammatory  responses  (33- 
35).  The third,  or/33,  subfamily  includes the receptors for 
vitronectin (VnR) (44, 52) and thrombospondin (37) as well as 
platelet glycoprotein lro/IIIa, a receptor for multiple ligands 
(fibrinogen,  yon Willebrand's  factor,  vitronectin  [Vn], and 
fibronectin  [Fn]) (22, 23, 42). Recently, great progress has 
been made in the molecular cloning and structural  analysis 
of members of the integrin  superfamily.  In both c~ and/5 
chains,  a large extracellular  amino-terminal  domain is fol- 
lowed by a single membrane-spanning  helix and a relatively 
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main;  the ~ subunit contains  a cysteine-rich  domain that is 
extensively  S-S bridged, while o~ subunits  have several cat- 
ion-binding  domains (3, 4,  16, 29,  33, 43, 53). 
The biosynthesis and assembly of integrins  has also been 
examined recently; it seems that assembly of the ¢x~ hetero- 
dimer is required for ligand binding activity and that associa- 
tion precedes maturation of the complex in the Golgi appara- 
tus  and  expression of the  functional  integrin  on  the ceil 
surface (1, 12, 27). The binding of ligands by many, but not 
all, integrins  involves recognition  in the ligand molecule of 
a tripeptide sequence, Arg-Gly-Asp (RGD), found in numer- 
ous extracellular  matrix proteins; however, regions flanking 
the RGD sequence, as well as more distant sites, may deter- 
mine the affinity and specificity of interactions  between pro- 
tein ligands and integrin receptors (31, 40, 45, 57). Recently, 
the putative binding  sites for the RGD sequence have been 
identified  in the ~ chains of gp llb/IIIa and the VnR by use 
of photoactivatable  RGD-containing  peptides (18, 49). It has 
also become clear  recently that  some aspects of integrin 
function in cells are regulated by protein kinase C and by cy- 
chc nuc!eotide-dependent kinases (17)• Thus, the biochemi- 
cal basis of integrin  function is beginning  to be defined. 
Cellular interactions mediated by integrins, including those 
involving the FnR, are vital to many significant physiological 
and pathological  processes. This would include embryonic 
cell migration  (19, 20), cell and tissue differentiation  (39), 
tumor cell metastasis  and invasion (24, 30), cytoskeleton- 
plasma membrane associations (51), and modification of the 
morphology and behavior of transformed cells in culture (11, 
12). Studies of the role of the FnR in particular cellular or 
developmental  processes have usually relied on interference 
with normal ligand-receptor binding by means of proteolytic 
fragments  of fibronectin,  synthetic  RGD peptides, or anti- 
bodies to Fn and/or FnR (6, 24, 30, 38, 51, 57). Such results 
are equivocal in that  these moieties may or may not have 
similar effects upon binding to the FnR as does the authentic 
ligand;  further,  the magnitude and duration  of these effects 
may be quite variable in cell culture or during in vivo situa- 
tions. We therefore sought an unambiguous way to delineate 
the role of the FnR in various cellular processes and, for that 
purpose, have isolated a series of stable FnR-deficient  vari- 
ants from the Chinese hamster ovary (CHO) cell line, using 
monoclonal antibodies to FnR as tools for enrichment and 
selection.  A similar  strategy could readily be applied to any 
other integrin  receptor for which antibodies are available. 
Specifically,  these variants  should allow us, first,  to deter- 
mine the relative  importance of the FnR,  compared with 
other integrins and with nonintegrin-mediated  mechanisms, 
in determining  cellular adhesion, morphology,  and motility 
on various extracellular  matrix substrata.  Second, the intra- 
cellular signals generated upon ligation of FnR are unknown; 
having a true negative control may allow for their discovery. 
Third, elucidation of receptor function at the molecular level 
should be facilitated by using these variants  as transfection 
hosts for intact or modified integrin  cDNAs. Fourth, study 
of FnR-deficient cells may provide important insights into the 
regulation  of integrin  expression. 
In this  study,  we have  selected a  series of CHO clones 
which are either partially or virtually completely deficient in 
the cell surface expression of FnR. These clones were select- 
ed by using  monoclonal antibodies directed against  intact 
FnR or against the/~ subunit of the receptor.  Our studies in- 
elude evaluation of  growth characteristics,  cell adhesion, cell 
motility, surface expression, and total cellular expression of 
FnR, as well as assessment of messenger RNA levels for this 
integrin. 
Materials and Methods 
Cell Culture 
CHO cells were grown and maintained as previously described (17, 26) ei- 
ther as monolayers in ~-MEM  (Gibco Laboratories,  Grand Island,  NY) 
supplemented with  10% FCS (Hazelton Research Products,  Lenexa, KS) 
and 1% antibiotic-antimycotic mixture (Gibco Laboratories) or in suspen- 
sion culture where the FCS was reduced to 5 %. Monolayers were routinely 
passaged with trypsin-EDTA (Gibco Laboratories), and cell number was 
determined  with  an  ElectroZone  celloscope  (Particle  Data,  Inc.,  Eim- 
hurst, IL). 
Variant Cell Enrichment 
Subconflucot cell monolayers were harvested with 0.02% EDTA in PBS at 
4°C, or log-phase suspension-grown cells were washed three times with cold 
PBS. All subsequent operations were performed at 4°C in ~-MEM contain- 
ing  1%  BSA,  maintaining  sterility.  Cells  were  stained  by  indirect  im- 
munofluorescence, using anti-FnR mouse monoclonai antibodies PBI (spe- 
cific  for the intact Chinese  hamster FnR)  or 7E2  (specific  for Chinese 
hamster fll chain) as primary antibody (7, 9) and FITC-conjugated rabbit 
anti-mouse IgG (CappelI-Organon Technika, Malvern, PA) as a secondary 
reagent. Antibody staining reactions were virtually complete after 15 min 
and were followed by extensive washing in ¢~-MEM, 1% BSA. Background 
staining was assessed by omitting primary antibody. Cells were separated 
by fluorescence-activated cell sorting (FACS) on an Epics IV flow cytometer 
(Coulter Electronics Inc., Hiaieah, FL) equipped with a 488-nm argon laser 
and were gated for viability (forward angle light scatter) and low fluorescein 
fluorescence.  Cells selected for low fluorescence were initially plated di- 
rectly into 96-well plates at three cells per well and regruwn to confluence. 
Cultures with low anti-FnR binding were then batch-sorted two to four addi- 
tional times, until the mean fluorescence of the population of sorted cells 
was '~,40 % or less of the intensity of the unsorted CHO cell population. The 
final batch-sorted populations were allowed to recover for 2-3 d and then 
cloned by limiting dilution at 0.5 cells/well and screened by ELISA. 
Screening and Selection 
Progeny of individual clones were screened for low FnR expression in intact 
cells by ELISA. Cells were plated in microtiter plates precoated with poly- 
lysine (1  mg/ml;  50  /~l/well)  and gelatin  (0.1%;  100/~l/well)  and  were 
screened using PBI or 7E2 mAb as primary antibody followed by sheep 
anti-mouse/~-gaiactosidase conjugate and enzyme substrate according to 
the manufacturer's instructions (Bethesda Research Laboratories, Gaithers- 
burg, MD).  Plates were read at 405 run on a microplate autoreader (Bio- 
Tek Instruments, Inc., Winooski, VT).  Selected clones with low FnR ex- 
pression were rescreened over a period of I mo to be certain that receptor 
expression was stable. These clones were also evaluated in terms of their 
expression of a cell surface antigen (6C10) unrelated to integrins, using a 
monocloual antibody to this molecule (6), and in terms of expression of 
VnR, a member of the/~3 subfamily of integrins, using a polyclonal anti- 
VnR antibody (Telios, La Jolla, CA). 
Adhesion Assay 
Bovine plasma Fn was prepared as previously described (48). Vn was pre- 
pared from human plasma as described by Ruoslahti et al., (46) except that 
fast performance liquid chromatography (ion exchange) was performed on 
a Mono Q column (Pharmacia Fine Chemicals, Piscataway, NJ) with a 20 
mM Tris starting buffer, pH 7.6, in the absence of urea.  Ln was obtained 
from Collaborative Research (Bedford,  MA).  Fn,  Vn,  and Ln substrata 
were prepared by allowing varying concentrations of these proteins to ad- 
sorb to wells of tissue culture-grade 48-well plates for 2  h at 37°C.  The 
plates were then washed in PBS, blocked with 3 % BSA in PBS for 1 h at 
3"/°C, and finally washed four times with a-MEM containing 1% BSA and 
20 mM Hepes, pH 7.3 (adhesion buffer). Cells were metabolically labeled 
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ttCi/ml,  1,000  Ci/mM;  ICN Radiochemicals,  Irvine, CA),  washed three 
times, and resuspended in adhesion buffer to a concentration of 1-5  ×  105 
cells/ml. Attachment was allowed to proceed in a 370C incubator for varying 
times, at the end of which unattached cells were removed by washing the 
substrata with adhesion buffer (17). Attached cells were lysnd with 2 % SDS, 
and the lysate was transferred to scintillation vials for counting. All assays 
were performed in triplicate, and the results are expressed as either a per- 
centage of the total number of ceils or as a percentage of the positive control. 
Cell Motility Assays 
Cell motility in the presence of Fn was measured essentially as described 
by Albini et al. (2) in Boyden blind cell chambers (Nuclepore, Pieasanton, 
CA)  fitted  with  13-ram  polyvinylpyrrolidone-free  polycarbonate  filters 
(8/~m pore size). The lower chambers were filled with 3T3 cell-conditioned 
medium (2) supplemented with 30 ~g/mi Fn. Suspension-cultured, washed 
CHO cells (3-5  ×  105) in ~-MEM containing 0.1% BSA were added to the 
upper chambers to initiate the experiment. After a 9-h incubation at 37°C, 
the medium was removed from the upper chambers and any cells remaining 
on the upper surfaces of the filters were removed by scraping with cotton- 
tipped applicators. Cells on the undersides were fixed by flooding with Car- 
noy's fixative and stained with hematoxylin and eosin.  Filters were then 
mounted on slides, and cells in random microscopic fields were counted. 
Under the described conditions, ,x,200 wild-type cells were counted on the 
filter's lower chamber side per microscope field. All experiments were per- 
formed in triplicate. 
Immunoaffinity  Resins 
Antibody-coupled AItigel 10 resins were prepared according to Brown and 
Juliano (7) as modified by Sczekan, M. M., and R. L. Juliano (manuscript 
submitted for publication). Antibodies used were 7E2 mAb (anti-CHO/31 
chain), PBI mAb (anti-CHO intact FnR), and anti-gp140, a goat anti-FnR 
polyclonal antibody (7, 9). 
Surface Labeling and A nalysis 
Suspension-grown CHO cells, washed three times in cold PBS, were radio- 
iodinated with Nat25I (200 ttCi/107 cells; ICN Radiochemicals) using Iodo- 
Gen according to the manufacturer's instructions (Pierce Chemical Co., 
Rockford, IL). Labeled cells were incubated with lysis buffer (0.5 ml/2  x 
107 cells) containing 10 mM Tris, pH 7.4,  150 mM NaCi, 3 mM iodoacet- 
amide, and  100 mM n-octyI-B-D-glucopyranoside on ice for 1 h.  Lysates 
were clarified by centrifugation at 12,000 g  for 10 rain. The supernatant 
fractions were then gently mixed overnight at 4°C with immunoattinity resin 
that had been equilibrated in lysis buffer. After washing the pelleted resin 
three times with lysis buffer, adsorbed protein was eluted from the resin by 
boiling for 5 rain in SDS-sample buffer without B-mercaptoethanol followed 
by centrifugation to pellet the resin.  Eluates representing equivalent cell 
numbers were electrophoresed on 7.5% polyacrylamide gels as described 
by Laemmli (37). Gels were dried and autoradiographed with XAR film 
(Eastman Kodak Co.,  Rochester, NY). 
lmmunoblotting 
Lysates of unlabeled cells were prepared as described for surface labeling. 
FnR protein was partially purified using wheat germ agglutinin coupled to 
agarose (Vector Laboratories, Burlingame, CA) and with an immunoaflinity 
resin.  Protein was elutnd and electrophoresed as described above, trans- 
ferred to nitrocellulose, blotted with anti-gpl40 polyclonai antibody fol- 
lowed by t25I-protein A, and autoradiographed as described by Brown and 
Juliano (8) as modified by Sczekan, M. M., and R. L. Juliano (manuscript 
submitted for publication). 
Preparation of  cDNA Probes 
A eDNA representing part of the sequence of hamster FnR a  chain was ob- 
tained as follows. CHO cell poly A + RNA (14) was used to prepare cDNAs 
using avian myeloblastosis virus reverse transcriptase and oligo dT priming 
(41).  The cDNAs were used to construct a hgtll expression library (Stra- 
tagene, La JoUa, CA) that contained '~1.6  ×  106 recombinants. The gtll 
vectors were plaqued on Escherichia coil YI090, and lysis and expression 
were induced. The plaques were then probed with our goat anti-FnR affin- 
ity-purified antibody  (anti-gp140)  followed by  rabbit anti-goat  IgG and 
125I-protein  A. Positive plaques were recloned until all plaques tested posi- 
five. Antibodies bound to fusion proteins from positive plaques, when sub- 
sequently eluted, bound specifically to the o~ but not/~ chain of authentic 
FnR (data not shown). Thus, the positive clones likely represented FnR 
eDNA.  Positive gtll clones were restricted with Eco RI, and the inserts 
were sized by agarose gel electrophoresis; selected inserts ranged from 0.93 
to 2.25 kb. Inserts were subcloned into the pGEM3 plasmid vector (Pro- 
mega Biotec, Madison, WI) followed by transformation ofE. coli AGI with 
the vector (25). Subcloning success was determined by restricting out the 
inserts from purified plasmid and comparing insert size with that of the 
original gtll vectors by agarose gel electruphoresis. Using the T7 and SP6 
promoters of the pGEM3 vector, we have partially sequenced an 0.97-kb 
insert using the dideoxy technique (47). Sequencing 1-200 bases into each 
site and use of homology search programs (International Biotechnoiogies, 
Inc., New Haven, CT) indicates substantial homology to the published se- 
quence for human FnR ot chain (3). Our insert seems to lie in the middle 
of the coding region approximately from bases 880 to 1,810. Conversion to 
amino acid sequence indicates stretches of almost perfect homology to hu- 
man FnR c~. Partial amino acid sequence comparison of hamster 0.97-kb 
FnR ¢c clone with human FnR ¢x is as follows. The hamster and human FnR 
clone SP6 sites are EDFVAGVP and EDFVAGVP, respectively; the hamster 
and  human  FnR  clone  "1"7 sites  are  GALEDCREMKIYL-RNESE  and 
GAREDCREMKIYLRNESE,  respectively. A full sequence of the hamster 
FnR c~ chain is being completed (Hussein, S., and R. L. Juliano, manuscript 
in preparation).  Radioactive (35S) eDNA probes were prepared  from the 
hamster ~ chain 0.97-kb insert from the Biuescribe plasmid (as a negative 
control) and from a ~l eDNA (as a positive control) by random priming 
(21) using a protocol from the Promega Biotec technical manual. A human 
/~l chain eDNA clone was kindly provided by Dr. L. Fitzgerald (Cor Ther- 
apeutics,  South San Francisco, CA). 
Dot Blots 
Total RNAs from wild-type and FnR-deficient CHO cell variants were pre- 
pared  (14).  Hybridizations  were  done in dot-blot  format using a  slight 
modification of the procedure described by Perbai (41),  including 40 mM 
sodium phosphate in the hybridization solutions. 
Results 
Variant Selection and Growth Characteristics 
Early attempts at directly selecting variants expressing low 
levels of FnR by a single flow cytometric run resulted in cells 
with unstable levels of receptor expression, presumably ei- 
ther because normal cells overgrew deficient variants or be- 
cause populations initially identified as low expressors were 
under some unknown transient stress. Therefore, the strategy 
of iterative FACS was used. Cells were first sorted by FACS 
with an autoclone attachment at three cells per well and 
allowed to regrow  to confluence. Gated cells represented 
<0.1%  of the population. Of the 107 cells sorted, only 3 of 
the 253 wells plated contained low expressors as determined 
by ELISA. Two of the three resulting populations were then 
expanded and batch-sorted several  times; the third popula- 
tion was frozen away for future use. The first population then 
required four batch sorts followed by regrowth periods be- 
fore cloning by limiting dilution resulted in clones with sta- 
ble, low expression of FnR, while the second population re- 
quired two batch sorts. Examples of fluorescence intensity 
histograms of these populations made at the beginning of the 
final sort are shown in Fig.  1 (the first and second popula- 
tions are shown in Fig. 1, A and B, respectively, as peaks 2). 
Compared with wild-type CHO cells, the population means 
of log-integrated green fluorescence for low FnR-expressing 
populations are shifted leftward. The first population dis- 
plays a mean fluorescence intensity of ,~,34  % of wild type, 
while that of the second population is ,~43% of wild type; 
further, in both populations, there are a substantial number 
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Figure 1. FACS  histograms of variant populations of CHO cells be- 
fore final sorting. Equivalent  numbers of wild-type and variant cells 
were washed with cold PBS, then treated with anti-FnR monoclo- 
nal antibodies followed  by staining  with fluorescein-conjugated  rab- 
bit anti-mouse IgG, and subjected to fluorescent analysis before 
sorting. Each peak represents 104 cells. (.4) First population or 
wild-type cells treated with 7E2 monoclonal as primary antibody. 
(B) Second population or wild-type cells treated with PBI mono- 
clonal antibody. (Peaks 1-3) nonspecific  staining (no primary anti- 
body), variant cell population, and CHO wild-type cells, respec- 
tively. 
of ceils that overlap the profile of the negative control (un- 
stained) population. Having obtained populations enriched 
in low expressing cells, it was then possible to efficiently 
clone and screen enough cells to find the rare FnR-deficient 
variants we sought. Using this approach it is not possible to 
determine the frequency of the FnR-defcient variants in the 
wild-type population since several rounds of enrichment oc- 
curred before final screening and selection. 
Based on the data from ELISAs using PB1 mAb, which 
binds only to the intact heterodimer, the clones arising from 
the first population all express ,v20 % as much intact recep- 
tor as wild-type cells, while clones arising from the second 
population all express only ,,o2  % of wild-type levels (Table 
I). (Since variations of 2 % are near the level of experimental 
error of the ELISA assay,  our designation of clones as ex- 
pressing "2 %; of FnR simply means that very low levels of 
expression were observed.) There is no way of knowing if 
this is simply happenstance, if there is some bias in the in- 
dividual enrichment processes, or if all the clones isolated 
from each population represent the progeny of a single vari- 
ant cell in each population. It should also be noted that the 
levels of expression of the FnR mAb epitopes PB1 and 7E2 
are not equivalent in the low expressing cells. There is much 
more 7E2 epitope than PB1 epitope, especially in the clones 
arising from the second population. For the sake of conve- 
nience we will henceforth refer to clones originating from the 
first enriched population as "20 %" clones and those originat- 
ing from the second population as ~2 %" clones, realizing that 
Table L ELISA of CHO Clones* 
Primary antibody 
Clone  PBI  7E2  6C10 
1-23  15  +  8  24  -t-  14  97  +  11 
14-16  24  +  2  34  5:8  92  5:4 
21-4  18  5:8  24  5:8  103  +  7 
B2  2  5:  1  20  5:7  87  +  17 
D1  1  5:2  24  5:5  91  5:  11 
9  1+2  205:4  92+17 
23  1  5:2  23  95  5:13 
25  0.4  5:0.8  20  5:2  96  -k  1 
* Results are expressed as the mean +  SD of at least four experiments using 
PBI  and  6C10  as  primary  antibodies and two  experiments using 7E2  as 
primary antibody done over a period of at least I too. Each experiment consist- 
ed of at least triplicate  samples of each clone tested. Data are expressed as the 
percentage of the positive control, CHO wild-type cells. 
there are in fact subtle differences among individual clones 
within each group. 
To ascertain that the low level of binding of anti-FnR anti- 
bodies did not represent a general defect in cell surface gly- 
coprotein display,  ELISAs were done using an irrelevant 
rnAb (6C10) against a nonintegrin CHO cell surface glyeo- 
protein (6).  All clones deficient in FnR showed a  normal 
level of 6C10 antigen present on their surfaces as compared 
with wild-type  cells (Table I). Preliminary observations us- 
ing a  commercial anti-VnR antibody suggest that FnR-de- 
ficient variants display normal amounts of VnR on their sur- 
faces (data not shown). 
Growth curves of clones from both populations were com- 
pared with that of wild-type cells.  Clones from the first 
population (1-23, 14-16, and 21-4) expressing ,x,20% of wild- 
type levels  of FnR and clones B2 and 25 from the second 
population behaved identically to wild-type cells with aver- 
age doubling times of ,x,14 h. Three of the clones from the 
second population (expressing ,'~2  % of wild-type levels of 
FnR) grew somewhat more slowly. Clone D1 had a doubling 
time of 18 h, while clones 9 and 23 had doubling times of 
20 h. There seems to be no correlation of growth rates with 
the level of expression of receptor since some clones with 
very low FnR expression have equivalent doubling times to 
wild-type cells: for example, 15 h for clone B2 and 14 h for 
clone 25. 
Adhesion to Substrata 
Maximum adhesion of wild-type cells occurred on surfaces 
coated with 1 pg/ml Fn (Fig. 2). Clones expressing levels of 
receptor at 20% of  wild type (1-23, 14-16, and 21-4) displayed 
similar adhesive efficiencies as wild-type cells on surfaces 
coated with various amounts of Fn. Almost no cells from 
clones displaying ~2 % FnR (clones 132, D1, 9, 23, and 25) 
adhered to substrata coated with increasing amounts of Fn 
within the 90 rain of the experiment (see below). To assess 
whether FnR expression at a level of 20% of wild type places 
other limitations on the variants' abilities to adhere to Fn- 
coated  substrata,  we  examined how  rapidly these clones 
could adhere to a limiting concentration of  Fn on the substra- 
tum. At a concentration of 0.2 #g/ml Fn, clones expressing 
FnR at 20% of  wild type adhered more slowly than wild-type 
ceils  (Fig.  3),  but,  at the  end of the 90-min incubation 
period, the fraction of adherent cells approached that of wild 
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Figure 2. Efficiency of adhesion of CHO cell variants to Fn-coated 
substrata. Tissue culture plates were coated with various concentra- 
tions of Fn for 2 h at 37°C in PBS and then blocked with BSA as 
in Materials and Methods. Cells of wild-type or 20% clones meta- 
bolically  labeled  overnight with  35S-Trans label  were washed in 
PBS and resuspended  at 5  ×  lOs cells/ml and allowed to adhere 
for 1.5 h at 37°C. The adherent cells were recovered and analyzed 
for radioactivity as described, and the number of adherent cells was 
calculated.  (o) Wild-type cells;  (A) clone  1-23; (~) clone  14-16; 
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Figure 4.  Kinetics of adhesion of CHO variants to a nonlimiting 
concentration of Fn. Tissue culture plates were coated with 1 #g/ml 
of Fn and then blocked with BSA. CHO wild-type and 2 % variant 
cells were prelabeled with ~5S as described in Materials and Meth- 
ods, washed, and resuspended at lOs cells/m1 in ot-MEM contain- 
ing 1% BSA and 20 mM Hepes, pH 7.3, and allowed to adhere at 
37°C for different time intervals. The attached cells were recovered 
and analyzed for radioactivity as described,  and the number of ad- 
herent cells was calculated. (o) Wild-type cells; (o) clone B2; (A) 
clone DI; (v) clone 9; (m) clone 23;  (,) clone 25. 
type. These results suggest that only when receptor expres- 
sion falls below ~,20% of wild type, is the cell's ability to 
form stable adhesions to Fn-coated substrata markedly im- 
paired. In other words, there seem to be numerous "spare 
receptors" for Fn-mediated adhesion in wild-type cells, as we 
have previously noted  (8).  By contrast,  clones  displaying 
~2% FnR do not adhere to substrata coated with noulimiting 
concentrations of Fn (1  /~g/ml)  even after 2 h  (Fig. 4). 
Similar experiments were repeated on Vn-coated substra- 
ta. In all cases the variant cells behaved essentially the same 
as wild type: adhesion to increasing amounts of Vn was max- 
70 
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Figure 3. Kinetics of the adhesion of variants to a limiting concen- 
tration of Fn. Tissue culture plates were coated with 0.2 pg/ml of 
Fn and then blocked with BSA. CHO wild-type cells and 20% vari- 
ants were metabolically labeled with 3sS as described in Materials 
and Methods, washed, resuspended to a concentration of lO  s cells/ 
ml in c~-MEM containing 1% BSA and 20 mM Hepes, pH 7.3, and 
allowed to adhere at 37°C for different time intervals. The attached 
cells were recovered and analyzed for radioactivity as described, 
and the  number of adherent  cells was calculated.  (o) Wild-type 
cells;  (A) clone  1-23; (n) clone  14-16; (O) clone 21-4. 
imum at ~5 #g/ml (data not shown). All variants displayed 
kinetics of adhesion similar to wild-type cells over a 2-h time 
course on Vn substrata (Fig. 5). With Vn at a limiting concen- 
tration (0.5/zg/ml), clones expressing 20%  FnR compared 
with wild-type cells were at least as efficient as wild-type 
calls in forming stable adhesions (Fig. 5 A). At a nonlimiting 
concentration  of Vn  (5  #g/ml),  clones  expressing  2%  of 
wild-type levels of FnR were also identical in behavior to 
wild-type cells (Fig. 5 B); this should be contrasted with the 
parallel experiment on Fn substrata (Fig. 4). The 20 % clones 
were also tested on Ln substrata and were found to attach as 
efficiently as wild-type cells (data not shown). These results 
indicate that the variant populations have an adhesion defect 
only for Fn substrata, while other integrin-mediated adhe- 
sive mechanisms remain functional. 
Phase-contrast photomicrographs reveal differences in abil- 
iCy to spread on Fn- or Vn-coated substrata among different 
clones. A representative clone from each population is shown 
in Fig. 6. A variant expressing 20% FnR (clone 1-23) spread 
nearly as well as wild-cype cells on Fn, but the cell margins 
were irregular. Those few cells from a variant expressing 2 % 
FnR (clone 25) that adhered on a high concentration of Fn 
were neither spread nor flattened. On 5 #g/mi Vn, clones ex- 
pressing 20%  FnR  were indistinguishable  in morphology 
from wild-type cells.  Clones expressing 2%  FnR demon- 
strated some variation in their response on Vn: clones B2 and 
25 flatten and also spread to a slight extent, hut clones D1, 
9,  and 23  neither  flatten nor spread although they adhere 
quite well. Thus, the ability of cells to adhere to a substratum 
(see Fig. 5) is clearly distinct from the ability of those cells 
to spread on the same substratum. It is not known whether 
the variation in the morphologies of 2% variants on Vn is due 
to subtle differences in VnR abundance or to clone-to-clone 
differences in cytoskeletal or metabolic activities involved in 
cell spreading. The failure of  the variants expressing 2% FnR 
to spread on Vn substrata suggests that FnR and VnR cooper- 
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Figure 5. Kinetics of the adhesion of CHO wild-type and variant 
cells to Vn-coated substrata. Tissue culture plates were coated with 
0.5 #g/ml (4) or 5 #g/ml (B) Vn and then blocked with BSA. CHO 
wild-type and variant cells were metabolically labeled with 35S as 
described in Materials and Methods, washed, resuspended to a con- 
centration of lO  s cells/ml in a-MEM containing 1% BSA and 20 
mM Hepes, pH 7.3, and allowed to adhere at 37°C for different time 
intervals. The attached cells were recovered and analyzed for radio- 
activity as described, and the number of adherent cells was calcu- 
lated. The percent of total cells attaching during 120 min ranged 
from 50 to 90%; data were normalized using the number of cells 
attached at 120 min as 100%. In A: (o) wild-type cells; (zx) clone 
1-23; (n) clone 14-16; (<>) clone 21-4. In B: (o) wild-type cells; 
(o) clone B2; (A) clone DI; (v) clone 9; (u) clone 23; (,) clone 25. 
ate in some way to promote cell spreading on Vn or that FnR 
can recognize Vn under some circumstances and that this is 
necessary for fully developed cell spreading in CHO cells. 
Cell Motility 
The data shown in Fig. 7 indicate that there are major differ- 
ences in  the motile behavior of wild-type cells and FnR- 
deficient variants. There was virtually no movement of clones 
expressing ,o2% levels of FnR from the upper to lower sur- 
faces of the test filters. Clone 25, which expresses very low 
levels of FnR, was an outlier in this regard since some degree 
of cell motility was observed in this case. The basis of this 
difference is unclear at present; we are exploring the possi- 
bility that the clone 25 cells can use an adhesion factor other 
than Fn that may be present in small amounts in the assay 
system. The number of cells traversing the filters for clones 
expressing ",,20% levels of FnR was 20-40% of wild type. 
These differences were not due to the initial adhesive be- 
havior of the cells since cells of all clones could be observed 
to attach to the upper surfaces of  the filters. The observed cell 
movements represent directed cell motility along an Fn gra- 
dient since, when Fn was present in both upper and lower 
chambers, only a few wild-type cells traversed the filter; we 
have not yet determined whether this  directed movement 
represents chemotaxis or haptotaxis. It is remarkable that in 
the clones expressing ,o20% of wild-type levels of FnR, im- 
pairment of directed cell motility in the presence of Fn was 
much more profound than impairment of  cell adhesion (com- 
pare with Fig. 2). 
Surface Labeling 
To investigate the biochemical nature of the FnR deficiency 
at the level of the plasma membrane,  we surface-labeled 
suspension-grown cells with Na'25I and extracted the mem- 
brane proteins with a/3-D-octylglucoside-containing buffer. 
Monoclonal antibody affinity supports  were then used to 
selectively immunoprecipitate proteins expressing PB1 epi- 
tope or 7E2 epitope; SDS eluates of the washed supports 
were electrophoresed under nonreducing conditions, and the 
dried gels  were subjected to autoradiography.  Results for 
clones  expressing  "o20%  of wild-type levels  of FnR  by 
ELISA are shown in Fig. 8, while results of clones express- 
ing "o2 % levels of FnR are shown in Fig. 9. 
Purification with mAb PB1 (specific for the intact FnR) 
yielded two strongly labeled bands of about equal intensity 
from wild-type cells (Figs. 8 and 9, lanes A). Clones express- 
ing 20% FnR based on ELISA displayed two weaker bands 
that comigrated with those from wild-type cells (Fig. 8, lanes 
B-D). Clones expressing 2 % FnR displayed no labeled ma- 
terial, indicating essentially a complete lack of intact FnR on 
their surfaces (Fig. 9, lanes B-F). Although there is clearly 
a qualitative similarity between results obtained by surface 
labeling (Fig. 8) and by ELISA (Table I) for the 20% clones 
in that surface labeling is markedly reduced compared with 
wild type, there is not a good quantitative correlation be- 
tween these two techniques. For example, clones b23 and 21- 
4  reproducibly give similar ELISA values but have quite 
different intensities of surface labeling. These discrepancies 
may simply be due to inherent differences in the abilities of 
these two techniques to reproducibly quantitate subtle altera- 
tions in surface antigen expression, with the ELISA assay 
likely to be more reliable. 
Clones  that  express very low  levels of FnR,  either by 
ELISA (Table I) or by surface labeling and immunoprecipita- 
tion (Fig. 9, lanes A-F) using PB1 antibody, still express rel- 
atively high levels of 7E2 epitope (Table I), indicating con- 
tinued presence of a/3 subunit on their surfaces. This could 
conceivably be due to surface expression of a "free"/3 chain 
or, perhaps more likely, to continued expression of/3 in as- 
sociation with another (non-FnR) a  chain. Surface labeling 
and immunoprecipitation with 7E2 of clones expressing 2 % 
FnR resulted in purification of two labeled bands (Fig. 9, 
lanes H-L). The faster component comigrated with authentic 
/3 subunit from wild-type cells, although it was reduced in 
intensity.  A  slower moving component was also observed 
(best seen  in  Fig.  9,  lanes H-J) that  seemed to migrate 
slightly ahead of FnR ot chain (Fig. 9, lane A). This compo- 
nent (as well as some/3 chain) could also be observed in 7E2 
immunoprecipitates from surface labeled lysates of wild- 
type cells exhaustively precleared with PB1 (data not shown). 
These results suggest that in clones that express only 2 % of 
The Journal of Cell Biology,  Volume 109, 1989  3162 Figure 6.  Morphologies of CHO wild-type and variant cells on Fn or Vn substrata. Washed CHO wild-type cells and variants (5  x  104 
in 0.5 nil) in (x-MEM containing 1% BSA and 20 mM Hepes, pH 7.3, were allowed to adhere for 30 min to 24-well tissue culture plate 
surfaces that had been precoated with either 1 t~g/ml Fn (A-C) or 5/~g/ml Vn (D-F). Unattached cells were washed from the wells with 
(x-MEM containing 1% BSA and 20 mM Hepes, pH 7.3, before the adherent cells were photographed using a Diaphot inverted phase pho- 
tomicroscope (Nikon Inc., Garden City, NY). (A and D) Wild-type  cells; (B and E) clone 1-23; (C and F) clone 25. A field with an unusually 
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Figure Z  Comparison of motilities between CHO wild-type cells 
and  FnR variant cells. NIH-3T3  fibroblast-conditioned medium 
supplemented with 30/~g/ml Fn was placed in the lower chamber 
of Boyden blind wells, and 3-5  ×  I(P cells in a a-MEM contain- 
ing 0.1% BSA was placed in the upper chamber. After 9 h, the blind 
wells were disassembled, the top side of the filter was cleaned, and 
cells on the bottom side were fixed, stained, and counted as de- 
scribed in Materials ~  Methods. The results arc expressed as the 
percent of wild-type cells per microscopic field that have migrated 
to the lower side of the filter. The data presented are the composite 
of four experiments. (Bars A-I) Wild-type  cells and clones 1-23, 14- 
16, 21-4, B2,  D1, 9, 23,  and 25, respectively. 
Figure 8. Electrophoretic analysis of afl~nityopurified receptor from 
20%  clones. Cells (2  x  l07)  were surface labeled with 400 ~Ci 
Na~25I, lysed in octyl glucoside-containing buffer,  and incubated 
with PB1-Affigel. The Affigel  was then washed, and bound material 
was eluted by addition of SDS sample buffer. Identical cell equiva- 
lents for each clone were loaded onto 7.5 % SDS nonreducing gels 
along with prestained molecular mass markers. When the dye front 
reached  the  bottom of the  gels,  the  gels  were  fixed in  0.3  M 
CuCI2, dried, and autoradiographed. (Lanes A-D) CHO wild-type 
cells, clone  1-23, clone  14-16, and clone 21-4,  respectively. The 
molecular masses of the standards to the fight of the gel are in 
kilodaltons. 
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2% clones. Cells (4  x  107) were surface labeled with 800 t~Ci 
Na~25I and lysed in octyl ghcoside--containing buffer, and each ly- 
sate was divided into two parts. Half of each lysate was incubated 
with  PBI-Affigel (lanes A-F)  and  half with  7E2-Affigel (lanes 
G--L). Receptor was eluted and electrophoresed, and the gel was au- 
toradiographed as in Fig. 9. (Lanes A-G) CHO wild-type cells; 
(lanes B and H) clone B2; (lanes C and I) clone DI; (lanes D and 
J) clone 9; (lanes E and K) clone 23; (lanes F and L) clone 25. The 
molecular masses of the standards to the right of the gel are in 
kilodaltons. 
Figure 10. Immunoblot of CHO wild-type and variant clones. Iden- 
tical cell equivalents (5  x  10  ~) of each clone were washed and 
then lysed in octyl glucoside-containing buffer. FnR was partially 
purified by treating the lysates with wheat germ agglutinin-agarose 
affinity resin. The eluates in SDS sample buffer were electropho- 
resed on 7.5% nonreducing polyacrylamide gels along with molec- 
ular mass markers. At completion, the protein was transferred from 
the gel to a nitrocellulose filter, and the nitrocellulose was blotted 
with anti-gpl40  goat polyclonal antibody (1 mg/ml) followed by 
rabbit  anti-goat  IgG  (1:10,000 dilution) and  t25I-protein A  (0.1 
#Ci/ml)  with extensive washing in between each step; thereafter, 
the filter was dried and autoradiographed. The molecular masses 
of the standards are given in kilodaltons. (Lanes A-E) CHO wild- 
type cells and clones 1-23, B2, 23, and 25, respectively. 
wild-type levels of FnR, a substantial amount of B chain con- 
tinues to appear on the surface and that some of this is as- 
sociated with a distinct, as yet unidentified, ot chain. It is un- 
likely that this or/3 heterodimer is itself an FnR since PB1 
antibody, which is directed solely against the hamster homo- 
logue of ots/3t, can completely inhibit CHO cell adhesion to 
Fn. The autoradiograms of Fig. 9, lanes H-L, clearly show 
that relatively more surface labeling of/3 chain than ot chain 
is seen in 7E2 immunoprecipitates of 2 % clones, especially 
clones 23 and 25; this may result from preferential labeling 
of/3 vs. ot chain. Alternatively, our results may suggest that 
some free/3 chain may emerge on the cell surface when ex- 
pression of  intact FnR is severely impaired. This observation 
contrasts somewhat with the more usual case where c~/3 as- 
sembly is a prerequisite for cell surface expression (1, 12, 27) 
but may be due to the major imbalance of ot and 8  chain 
production. 
lmmunoblots 
The lack of intact FnR on the cell surface in the variants may 
be  due  either  to  impairment  of the  biosynthesis  of FnR 
subunits or to failure of those subunits to assemble properly. 
To sort out this problem, whole-cell lysates were immuno- 
blotted with anti-FnR  goat polyclonal antibody and  125I- 
protein A; the results are shown in Fig. 10. Immunoblots of 
wild-type cells (Fig.  10, lane A) revealed three bands of la- 
beled material-the ot band,  the/3 band,  and a/3 subunit 
precursor at  140,  120,  and  ~,110  kD-in  agreement with 
previous observations  (8).  Clones  from both populations 
(Fig.  10, lanes B-E) have bands that comigrate with/3 and 
with pre-/3 bands from wild-type lysate, while the ot band 
was poorly detectable in 20% clones (Fig.  10, lane B) and 
not detected in 2% clones (lanes C-E). An interesting side- 
light is  that the relative amount of pre-/3  seems to be in- 
creased in all of the variants, thus suggesting that the matura- 
tion of pre-/3 is facilitated by the presence of ot subunits, as 
other have reported (27). 
RNA Blots 
To determine if mRNA levels for the ot subunit of FnR cor- 
related with levels of FnR protein expression in wild-type 
and variant cells, we performed dot blot hybridizations with 
total RNA isolated from each clone. Fig.  11 shows that the 
levels of ot chain mRNA parallel the levels of o~ chain and 
of intact FnR.  Clone 1-23 (a 20%  clone) has substantially 
less ot chain mRNA than wild-type cells, while the o~ mRNA 
level in clone 25 (a 2 % clone) was at background level. Par- 
allel  experiments  with  a  /31  chain  eDNA  probe  showed 
equivalent levels of mRNA in each of these clones. This was 
typical of results from other clones in each group. 
Discussion 
Although there has been tremendous interest recently in the 
structure and function of integrins, our understanding of the 
role of these molecules in cell and tissue behavior is still in 
a nascent state.  Much information on this topic can no doubt 
be gained by manipulating integrin function with antibodies 
or with peptide antagonists.  Many insights will also be gained 
by expression of integrin eDNA constructs in ectopic situa- 
tions; further, the use of  antisense constructs may also permit 
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ant cells. Serial dilutions of RNA from wild-type CHO cells and 
from clones 1-23 (20%) and 25 (2%) were loaded onto nitrocellu- 
lose and then hybridized with 35S-labeled eDNA probes: (,4) the 
0.97-kb CHO FnR tz chain probe; (B) the Bluescfibe plasmid-a 
negative control;  (C) a human/3~ cDNA. 
studies involving the suppression of  endogenous integrins. In 
addition to these approaches, however, the relatively straight- 
forward selection of clonal cell populations deficient in inte- 
grin expression may also contribute significantly to elucida- 
tion of the multiple biological roles of integrin molecules. In 
this report we have described the selection and partial char- 
acterizafion of CHO cell clones deficient in expression of 
FnR, one of the most studied members of the integrin super- 
family. 
The first important point to emerge from these studies is 
that expression of FnR is not essential for growth and divi- 
sion of CHO cells.  Thus,  some clones that express <2 % 
of wild-type levels of FnR, still display doubling times simi- 
lar to wild-type cells when grown on serum-coated culture 
dishes.  Presumably, the cells are able to use Vn  or other 
adhesive factors in  serum to maintain a  relatively normal 
looking morphology and to permit growth. One should keep 
in mind that CHO cells are anchorage independent and thus 
may rely less on functions mediated by adhesion receptors 
than might be the case for anchorage-dependent cell lines. 
Other types of cells are known to express relatively low lev- 
els of o~5/3~ and yet grow well (10, 13).  However, it is  in- 
teresting to note that the FnR can be lost from fibroblastic 
cells that normally express this molecule at high levels with- 
out impairment of cell replication. 
A  second significant point is that FnR abundance seems 
to be more critically involved in cell motility than in cell 
adhesion. Clones, such as 1-23 and 14-16, that possess ,x,20% 
of wild-type FnR levels seem to adhere quite well, albeit 
slightly more slowly, to Fn-coated surfaces and to assume an 
apparently normal morphology. This seems to support our 
previous finding that wild-type CHO cells have numerous 
spare receptors for Fn and that only a small fraction of the 
FnR population is used to form cell-substratum contacts (8). 
By contrast, cells with 20% of wild-type levels of FnR dis- 
played marked impairments in a motility assay that involved 
directed migration in the presence of an Fn gradient. It may 
be that the cells' ability to locomote on Fn, which involves 
repetitive formation and breakage of adhesive contacts and 
possibly recycling of FnR (5), may have a more stringent re- 
quirement for abundant receptor than does simple formation 
of adhesive contacts. This may have implications in terms of 
the possible  role of integrins  in  the  invasive behavior of 
malignant cells; our results suggest that highly invasive cells 
may need abundant integrin receptors to locomote through 
extracellular spaces. Our findings are also generally consis- 
tent with observations on human leukocyte adhesion defici- 
ency (LAD) (33-35). In LAD patients, leukocytes fail to pro- 
duce normal/~2 chain and assemble/32 integrins; these cells 
are markedly deficient in their ability to participate in control 
of infections or in inflammatory phenomena, an effect due 
in part to the inability of LAD cells to migrate  from the 
bloodstream to sites of inflammation. Thus, cells may need 
to increase expression or mobilization of integrins for loco- 
motion involved in tumor invasion, angiogenesis, or inflam- 
matory phenomena. 
A third interesting aspect of these studies is the observa- 
tion that the FnR-deficient phenotype in all the clones iso- 
lated is due to reduced levels of FnR a  mRNA and conse- 
quently reduced FnR a  chain production. In wild-type cells, 
abundant ct chain is detected by Western blotting with poly- 
clonal anti-FnR, and a  chain message is easily detected by 
dot blot with hamster c~ chain eDNA. In 2 % clones neither 
message  nor polypeptide chain  is  detectable,  while  in 
20% clones some message and approximately proportionate 
amounts of a  chain polypeptide are found. The defects ob- 
served in our variants seem to be restricted to FnR since ex- 
pression of VnR and ability to adhere to Vn is approximately 
normal in 20 and 2% clones; further, in 2% clones, with no 
FnR detectable by surface labeling,/3 chain partly associated 
with another o~ chain remains detectable. Failure to synthe- 
size substantial amounts of FnR o~ chain results in underex- 
pression of intact FnR at the cell surface; it also seems to 
result in accumulation of excess/3 chain precursor. This ob- 
servation is consistent with those from other laboratories, 
suggesting that tx chain synthesis is limiting and that/3 chain 
remains in precursor form until it combines with tx (27) or 
is  at least retarded in its maturation by the absence of ct 
chain. 
The nature of the defect leading to reduced levels of 
chain mRNA is unclear at present. One possibility is an al- 
teration in the 5' regulatory sequence of the FnR ot gene; 
other possibilities are a  structural mutation leading to pre- 
mature termination of transcription, production of unstable 
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recognized by our cDNA  probes.  We will attempt  to dis- 
criminate among these possibilities in future experiments. A 
somewhat surprising aspect of our work is the fact that all 
of the variant clones studied thus far have a defect in ot chain 
message levels. Thus far we have not identified any clones 
with a defect in/~ chain expression nor have we found variants 
that express aberrant but still recognizable ct or/3 chains. 
This  is  somewhat  surprising  since  7E2,  an  anti-/~  chain 
monoclonal antibody, was used during the process of enrich- 
merit of cell populations for FnR-deficient variants.  Further, 
the only known natural  defect of the integrin  superfamily, 
leukocyte adhesion deficiency (34), involves altered fl chain. 
It may be that ,v chain message expression involves complex 
control mechanisms, thus permitting multiple opportunities 
for variant  selection.  If so,  then further  study of some of 
these variants,  as well as the generation of additional vari- 
ants, could lead to significant insights into the regulation of 
integrin expression. 
An intriguing possibility for further work with these vari- 
ants concerns their possible use as host cells for DNA trans- 
fection experiments. It may be that the defect that prevents 
accumulation  of  normal  levels  of endogenous  t~  mRNA 
would also prevent  efficient expression of,  message pro- 
duced from a transfection vector.  If not, then these cells (es- 
pecially the 2 % variants)  could be used to express normal 
or modified FnR cDNAs against a background essentially 
devoid of endogenous receptor; thus,  both biochemical and 
functional studies could be readily conducted. 
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